Ghana COVID-19 Vaccinations and Financial Incentives
How to cite
Duch, Raymond. 2022. "Ghana COVID-19 Vaccinations and Financial Incentives." AEA RCT Registry. AEARCTR-0008775. https://doi.org/10.1257/rct.8775-3.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Achieving global vaccination against COVID-19 is a critical worldwide challenge. While COVAX is planning mass vaccination of Africa in 2022, there are substantial challenges. Cash incentives have been proposed as a way to improve the efficiency and equity of the roll-out in Africa. Recent experimental evidence suggests that financial incentives can promote the adoption of preventive health habits (Hussam etal 2022) and more specifically vaccine uptake (Campos Mercade etal 2021). To evaluate whether cash incentives affect the willingness to get the COVID-19 vaccine, we are undertaking a field experiment, designed and conducted in consultation with the University of Ghana and the Ghana Health Service. The experiment will evaluate the impact of cash incentives on vaccine uptake.
Intervention
The experiment has four treatments that are delivered in a short video:
Treatment 1: A placebo video that provides general information about the benefit of using solar power to charge household electrical appliances.
Treatment 2: Standard CDC COVID-19 vaccine promotional and information video.
Treatment 3: Low Cash Incentive treatment -- the first 30 seconds are identical to the CDC video -- the last 15 seconds inform viewers that that they will earn $3 if they provide proof of a COVID-19 vaccine within the next 6 weeks.
Treatment 4: High Cash Incentive treatment -- the first 30 seconds are identical to the CDC video -- the last 15 seconds inform viewers that that they will earn $10 if they provide proof of a COVID-19 vaccine within the next 6 weeks.
Experimental design
The randomized control trial is designed to measure the direct impact of financial incentives on individual vaccine update rates in the Ghana rural population. The clustered randomized control trial will randomly select 6,552 participants from selected rural households; in 312. villages and from 6 Ghana Districts. We adopted a cluster random assignment design in order to address spillover effects that could have important implications for evaluating the overall benefits (and costs) of implementing financial incentives for vaccine uptake.
Village clusters are randomly assigned to receive on of four video treatment arms: a placebo, a standard health message, a high cash incentive ($10) and a low cash incentive ($3). Randomly selected participants within a village will be assigned to one of the four video treatment arms. In addition, a proportion of subjects (25 percent) within village clusters assigned to one of the three treatment arms receive the placebo treatment. We incorporate placebo treatments in the design in order to facilitate the identification of both direct and indirect treatment effects that are decoupled from the delivery mechanism.
Design details
Materials
Papers from this trial
- @Article{Duchetal2023, author={Duch, Raymond and Asiedu, Edward and Nakamura, Ryota and Rouyard, Thomas and Mayol, Alberto and Barnett, Adrian and Roope, Laurence and Violato, Mara and Sowah, Dorcas and Kotlarz, Piotr and Clarke, Philip}, title={Financial incentives for COVID-19 vaccines in a rural low-resource setting: a cluster-randomized trial}, journal={Nature Medicine}, year={2023}, month={Dec}, day={01}, volume={29}, number={12}, pages={3193-3202}, abstract={We implemented a clustered randomized controlled trial with 6,963 residents in six rural Ghana districts to estimate the causal impact of financial incentives on coronavirus disease 2019 (COVID-19) vaccination uptake. Villages randomly received one of four video treatment arms: a placebo, a standard health message, a high cash incentive (60 Ghana cedis) and a low cash incentive (20 Ghana cedis). For the first co-primary outcome---COVID-19 vaccination intentions---non-vaccinated participants assigned to the cash incentive treatments had an average rate of 81{\%} (1,733 of 2,168) compared to 71{\%} (1,895 of 2,669) for those in the placebo treatment arm. For the other co-primary outcome of self-reported vaccinations 2{\thinspace}months after the initial intervention, the average rate for participants in the cash treatment was 3.5{\%} higher than for participants in the placebo treatment (95{\%} confidence interval (CI): 0.001, 6.9; P{\thinspace}={\thinspace}0.045): 40{\%} (602 of 1,486) versus 36.3{\%} (672 of 1,850). We also verified vaccination status of participants: in the cash treatment arm, 36.6{\%} (355 of 1,058) of verified participants had at least one dose of the COVID-19 vaccine compared to 30.3{\%} (439 of 1,544) for those in the placebo---a difference of 6.3{\%} (95{\%} CI: 2.4, 10.2; P{\thinspace}={\thinspace}0.001). For the intention and the vaccination outcomes, the low cash incentive (20 Ghana cedis) had a larger positive effect on COVID-19 vaccine uptake than the high cash incentive (60 Ghana cedis). Trial identifier: AEARCTR-0008775.}, issn={1546-170X}, doi={10.1038/s41591-023-02670-4}} https://doi.org/10.1038/s41591-023-02670-4
Cited by
No citation data available for this registration yet.